University of Melbourne researchers collaborating with Patrys receive $300K grant for anti-cancer treatment. [ + ]

Researchers at the University of Newcastle and the Cooperative Research Centre (CRC) for Asthma and Airways have found a way to stop inflammation, the main cause of asthma and other chronic diseases, by blocking malfunctioning microRNA molecules.

Through its Super Science initiative, the federal government is recognising the importance of information technology as an innovation driver.

FDA grants ChemGenex Priority Review for New Drug Application for Omapro. [ + ]

Mesoblast (ASX:MSB) ups and downs after trial successes. [ + ]

With New Zealand government recently opening the door to xenotransplantation trials – it is time for the Australian government to reconsider its moratorium. [ + ]

Up to $5 million will be made available in the current round of the NSW Science Leveraging Fund program and expressions of interest are now welcome.

A suite of anti-cancer reformulations developed by researchers at the University of Wollongong (UOW), is to be commercialised by new Australian start-up company, WarraPharm.

After a stroke or physical trauma, toxic metal ions flood into brain cells. Seong-Seng Tan has found a way to close the floodgates until the hazard passes. [ + ]

First full genome of the domestic horse sequenced. Sheds light on evolutionary history and human diseases. [ + ]

Banning gene patents could devastate Australian biotechnology industry, says IPTA. [ + ]

Even in the world's worst economic downturn since the Great Depression, Sydney-based Pharmaxis (ASX:PXS) managed to grow and open a new headquarters and factory. [ + ]

Australia's first DeltaVision OMX 3D-Sim Super-Resolution microscope, one of only two in the world, is part of the equipment in the University of Technology, Sydney's new microscopy facilities.

Traditional and next generation sequencing technologies combined for de novo sequence. [ + ]

Cochlear, CSL, Blackmores, Ansell, Biota, HealthScope [ + ]